Tag: HEA BIO FIN

Spyre Therapeutics Announces Grants of Inducement Awards

WALTHAM, Mass., June 6, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering,...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsHEA BIO FIN

Datavault AI Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Minister MacDonald concludes G7 Agriculture Ministers’ Meeting

SRAD Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Sportradar Group AG Class Action Lawsuit

Tag: HEA BIO FIN

Spyre Therapeutics Announces Grants of Inducement Awards

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us